☰

Austin M. Dulak, Ph.D. - Publications

Affiliations: 
2010 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wong GS, Zhou J, Liu JB, Wu Z, Xu X, Li T, Xu D, Schumacher SE, Puschhof J, McFarland J, Zou C, Dulak A, Henderson L, Xu P, O'Day E, et al. Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nature Medicine. PMID 29808010 DOI: 10.1038/S41591-018-0022-X  0.45
2016 Chen H(, Hattersley M, Rhyasen G, Dulak A, Wang W, Petteruti P, Dale I, Cheung T, Wen S, Castriotta L, Lawson D, Collins M, Ahdesmaki M, Walker G, Rabow A, et al. Abstract 4705: Therapeutic activity of bivalent BRD4 inhibitor AZD5153 in hematological cancers Cancer Research. 76: 4705-4705. DOI: 10.1158/1538-7445.Am2016-4705  0.305
2014 Beauchamp EM, Woods BA, Dulak AM, Tan L, Xu C, Gray NS, Bass AJ, Wong KK, Meyerson M, Hammerman PS. Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss. Molecular Cancer Therapeutics. 13: 475-82. PMID 24296828 DOI: 10.1158/1535-7163.Mct-13-0817  0.323
2013 Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genetics. 45: 478-86. PMID 23525077 DOI: 10.1038/Ng.2591  0.365
2012 Dulak AM, Schumacher SE, van Lieshout J, Imamura Y, Fox C, Shim B, Ramos AH, Saksena G, Baca SC, Baselga J, Tabernero J, Barretina J, Enzinger PC, Corso G, Roviello F, et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Research. 72: 4383-93. PMID 22751462 DOI: 10.1158/0008-5472.Can-11-3893  0.406
2012 Bandla S, Ruff D, Bass A, Beer DG, Zhou Z, Li A, Chen S, Thornton M, Luketich JD, Dulak A, Lin L, Pennathur A, Bennett R, Rothberg J, Godfrey TE. Abstract LB-410: Targeted resequencing of genes frequently mutated in esophageal adenocarcinoma using highly multiplexed Ion Torrent AmpliSeqTM technology and semiconductor sequencing Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-410  0.3
2011 Dulak AM, Gubish CT, Stabile LP, Henry C, Siegfried JM. HGF-independent potentiation of EGFR action by c-Met. Oncogene. 30: 3625-35. PMID 21423210 DOI: 10.1038/Onc.2011.84  0.538
2010 Dulak AM, Gubish CT, Siegfried JM. Abstract 4123: Induction of motility, invasion, and proliferation by wild-type EGFR depends on c-Met in NSCLC Cancer Research. 70: 4123-4123. DOI: 10.1158/1538-7445.Am10-4123  0.564
2008 Stabile LP, Rothstein ME, Keohavong P, Jin J, Yin J, Land SR, Dacic S, Luong TM, Kim KJ, Dulak AM, Siegfried JM. Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis. Molecular Cancer Therapeutics. 7: 1913-22. PMID 18645002 DOI: 10.1158/1535-7163.Mct-07-2169  0.516
Show low-probability matches.